aluates Reports

$ 0.0

Automative

Global Next Generation Monoclonal Antibodies Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-0J16558

Global Next Generation Monoclonal Antibodies Market Research Report 2023

BUY CHAPTERS

Global Next Generation Monoclonal Antibodies Market Research Report 2025

Code: QYRE-Auto-0J16558

Report

May 2025

Pages:96

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Amgen Inc

Pfizer Inc

Takeda

Daiichi Sankyo

Seagen

Astellas

Gilead Sciences

GSK

Immunocore Ltd

ADC Therapeutics

Bayer

Novartis

Lantheus

Aurobindo Pharma

Mundipharma

AbbVie

Next Generation Monoclonal Antibodies Market Size

The global market for Next Generation Monoclonal Antibodies was valued at US$ 16060 million in the year 2024 and is projected to reach a revised size of US$ 57570 million by 2031, growing at a CAGR of 20.3% during the forecast period.

Next Generation Monoclonal Antibodies Market

Evolution of monoclonal antibodies has resulted in the next generation of antibody therapeutics, with engineering to enhance characteristics such as target cell–killing potency. These include antibody–drug conjugates (ADCs), bispecific antibodies, engineered antibodies, antibody fragments, and nanobodies.

The Next Generation Monoclonal Antibodies Market is driven by the ongoing evolution of biopharmaceuticals and the remarkable potential of advanced monoclonal antibodies to treat an array of diseases, including cancer, autoimmune disorders, and infectious diseases. These next-generation antibodies offer enhanced therapeutic benefits through improved target specificity, reduced immunogenicity, and novel mechanisms of action. As precision medicine and biopharmaceutical innovations advance, the demand for next-generation monoclonal antibodies continues to surge. Innovations in antibody engineering, design, and production technologies further contribute to market expansion. However, a significant challenge for this market is the need to address complex drug development processes, high production costs, and evolving regulatory standards while ensuring accessibility and affordability for patients. Overcoming research and development challenges, optimizing manufacturing processes, and adapting to changing healthcare regulations are ongoing hurdles. Additionally, the market faces competition from traditional antibodies and other biologic therapies, necessitating continuous innovation to unlock the full therapeutic potential of next-generation monoclonal antibodies. Striking a balance between providing safe, effective, and accessible next-generation monoclonal antibody drugs while addressing scientific and regulatory challenges is essential for the continued growth of the Next Generation Monoclonal Antibodies Market.

This report aims to provide a comprehensive presentation of the global market for Next Generation Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Monoclonal Antibodies.

The Next Generation Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Next Generation Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Next Generation Monoclonal Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Next Generation Monoclonal Antibodies Market Report

Report Metric	Details
Report Name	Next Generation Monoclonal Antibodies Market
Accounted market size in year	US$ 16060 million
Forecasted market size in 2031	US$ 57570 million
CAGR	20.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antibody Drug Conjugate (ADC) Bispecific Antibody (BsAb) Antibody-radionuclide Conjugates
Segment by Application	Immune Diseases Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, Pfizer, Takeda, Daiichi Sankyo, Seagen, Astellas, Gilead Sciences, GSK, Immunocore, ADC Therapeutics, Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, AbbVie
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Monoclonal Antibodies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Next Generation Monoclonal Antibodies Market growing?

Ans: The Next Generation Monoclonal Antibodies Market witnessing a CAGR of 20.3% during the forecast period 2025-2031.

What is the Next Generation Monoclonal Antibodies Market size in 2031?

Ans: The Next Generation Monoclonal Antibodies Market size in 2031 will be US$ 57570 million.

Who are the main players in the Next Generation Monoclonal Antibodies Market report?

Ans: The main players in the Next Generation Monoclonal Antibodies Market are Roche, Amgen, Pfizer, Takeda, Daiichi Sankyo, Seagen, Astellas, Gilead Sciences, GSK, Immunocore, ADC Therapeutics, Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, AbbVie

What are the Application segmentation covered in the Next Generation Monoclonal Antibodies Market report?

Ans: The Applications covered in the Next Generation Monoclonal Antibodies Market report are Immune Diseases, Cancer, Other

What are the Type segmentation covered in the Next Generation Monoclonal Antibodies Market report?

Ans: The Types covered in the Next Generation Monoclonal Antibodies Market report are Antibody Drug Conjugate (ADC), Bispecific Antibody (BsAb), Antibody-radionuclide Conjugates

Recommended Reports

Monoclonal Antibody Therapy

Antibody Platform Technologies

Diagnostic Antibody Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next Generation Monoclonal Antibodies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antibody Drug Conjugate (ADC)

1.2.3 Bispecific Antibody (BsAb)

1.2.4 Antibody-radionuclide Conjugates

1.3 Market by Application

1.3.1 Global Next Generation Monoclonal Antibodies Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Immune Diseases

1.3.3 Cancer

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Next Generation Monoclonal Antibodies Market Perspective (2020-2031)

2.2 Global Next Generation Monoclonal Antibodies Growth Trends by Region

2.2.1 Global Next Generation Monoclonal Antibodies Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Next Generation Monoclonal Antibodies Historic Market Size by Region (2020-2025)

2.2.3 Next Generation Monoclonal Antibodies Forecasted Market Size by Region (2026-2031)

2.3 Next Generation Monoclonal Antibodies Market Dynamics

2.3.1 Next Generation Monoclonal Antibodies Industry Trends

2.3.2 Next Generation Monoclonal Antibodies Market Drivers

2.3.3 Next Generation Monoclonal Antibodies Market Challenges

2.3.4 Next Generation Monoclonal Antibodies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next Generation Monoclonal Antibodies Players by Revenue

3.1.1 Global Top Next Generation Monoclonal Antibodies Players by Revenue (2020-2025)

3.1.2 Global Next Generation Monoclonal Antibodies Revenue Market Share by Players (2020-2025)

3.2 Global Next Generation Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Next Generation Monoclonal Antibodies Revenue

3.4 Global Next Generation Monoclonal Antibodies Market Concentration Ratio

3.4.1 Global Next Generation Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next Generation Monoclonal Antibodies Revenue in 2024

3.5 Global Key Players of Next Generation Monoclonal Antibodies Head office and Area Served

3.6 Global Key Players of Next Generation Monoclonal Antibodies, Product and Application

3.7 Global Key Players of Next Generation Monoclonal Antibodies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Next Generation Monoclonal Antibodies Breakdown Data by Type

4.1 Global Next Generation Monoclonal Antibodies Historic Market Size by Type (2020-2025)

4.2 Global Next Generation Monoclonal Antibodies Forecasted Market Size by Type (2026-2031)

5 Next Generation Monoclonal Antibodies Breakdown Data by Application

5.1 Global Next Generation Monoclonal Antibodies Historic Market Size by Application (2020-2025)

5.2 Global Next Generation Monoclonal Antibodies Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Next Generation Monoclonal Antibodies Market Size (2020-2031)

6.2 North America Next Generation Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Next Generation Monoclonal Antibodies Market Size by Country (2020-2025)

6.4 North America Next Generation Monoclonal Antibodies Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Next Generation Monoclonal Antibodies Market Size (2020-2031)

7.2 Europe Next Generation Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Next Generation Monoclonal Antibodies Market Size by Country (2020-2025)

7.4 Europe Next Generation Monoclonal Antibodies Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Next Generation Monoclonal Antibodies Market Size (2020-2031)

8.2 Asia-Pacific Next Generation Monoclonal Antibodies Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Next Generation Monoclonal Antibodies Market Size by Region (2020-2025)

8.4 Asia-Pacific Next Generation Monoclonal Antibodies Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Next Generation Monoclonal Antibodies Market Size (2020-2031)

9.2 Latin America Next Generation Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Next Generation Monoclonal Antibodies Market Size by Country (2020-2025)

9.4 Latin America Next Generation Monoclonal Antibodies Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next Generation Monoclonal Antibodies Market Size (2020-2031)

10.2 Middle East & Africa Next Generation Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Next Generation Monoclonal Antibodies Market Size by Country (2020-2025)

10.4 Middle East & Africa Next Generation Monoclonal Antibodies Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Next Generation Monoclonal Antibodies Introduction

11.1.4 Roche Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Next Generation Monoclonal Antibodies Introduction

11.2.4 Amgen Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.2.5 Amgen Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Next Generation Monoclonal Antibodies Introduction

11.3.4 Pfizer Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Next Generation Monoclonal Antibodies Introduction

11.4.4 Takeda Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.4.5 Takeda Recent Development

11.5 Daiichi Sankyo

11.5.1 Daiichi Sankyo Company Details

11.5.2 Daiichi Sankyo Business Overview

11.5.3 Daiichi Sankyo Next Generation Monoclonal Antibodies Introduction

11.5.4 Daiichi Sankyo Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.5.5 Daiichi Sankyo Recent Development

11.6 Seagen

11.6.1 Seagen Company Details

11.6.2 Seagen Business Overview

11.6.3 Seagen Next Generation Monoclonal Antibodies Introduction

11.6.4 Seagen Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.6.5 Seagen Recent Development

11.7 Astellas

11.7.1 Astellas Company Details

11.7.2 Astellas Business Overview

11.7.3 Astellas Next Generation Monoclonal Antibodies Introduction

11.7.4 Astellas Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.7.5 Astellas Recent Development

11.8 Gilead Sciences

11.8.1 Gilead Sciences Company Details

11.8.2 Gilead Sciences Business Overview

11.8.3 Gilead Sciences Next Generation Monoclonal Antibodies Introduction

11.8.4 Gilead Sciences Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.8.5 Gilead Sciences Recent Development

11.9 GSK

11.9.1 GSK Company Details

11.9.2 GSK Business Overview

11.9.3 GSK Next Generation Monoclonal Antibodies Introduction

11.9.4 GSK Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.9.5 GSK Recent Development

11.10 Immunocore

11.10.1 Immunocore Company Details

11.10.2 Immunocore Business Overview

11.10.3 Immunocore Next Generation Monoclonal Antibodies Introduction

11.10.4 Immunocore Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.10.5 Immunocore Recent Development

11.11 ADC Therapeutics

11.11.1 ADC Therapeutics Company Details

11.11.2 ADC Therapeutics Business Overview

11.11.3 ADC Therapeutics Next Generation Monoclonal Antibodies Introduction

11.11.4 ADC Therapeutics Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.11.5 ADC Therapeutics Recent Development

11.12 Bayer

11.12.1 Bayer Company Details

11.12.2 Bayer Business Overview

11.12.3 Bayer Next Generation Monoclonal Antibodies Introduction

11.12.4 Bayer Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.12.5 Bayer Recent Development

11.13 Novartis

11.13.1 Novartis Company Details

11.13.2 Novartis Business Overview

11.13.3 Novartis Next Generation Monoclonal Antibodies Introduction

11.13.4 Novartis Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.13.5 Novartis Recent Development

11.14 Lantheus

11.14.1 Lantheus Company Details

11.14.2 Lantheus Business Overview

11.14.3 Lantheus Next Generation Monoclonal Antibodies Introduction

11.14.4 Lantheus Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.14.5 Lantheus Recent Development

11.15 Aurobindo Pharma

11.15.1 Aurobindo Pharma Company Details

11.15.2 Aurobindo Pharma Business Overview

11.15.3 Aurobindo Pharma Next Generation Monoclonal Antibodies Introduction

11.15.4 Aurobindo Pharma Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.15.5 Aurobindo Pharma Recent Development

11.16 Mundipharma

11.16.1 Mundipharma Company Details

11.16.2 Mundipharma Business Overview

11.16.3 Mundipharma Next Generation Monoclonal Antibodies Introduction

11.16.4 Mundipharma Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.16.5 Mundipharma Recent Development

11.17 AbbVie

11.17.1 AbbVie Company Details

11.17.2 AbbVie Business Overview

11.17.3 AbbVie Next Generation Monoclonal Antibodies Introduction

11.17.4 AbbVie Revenue in Next Generation Monoclonal Antibodies Business (2020-2025)

11.17.5 AbbVie Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Amgen Inc

Pfizer Inc

Takeda

Daiichi Sankyo

Seagen

Astellas

Gilead Sciences

GSK

Immunocore Ltd

ADC Therapeutics

Bayer

Novartis

Lantheus

Aurobindo Pharma

Mundipharma

AbbVie

List of Tables

Table 1. Global Next Generation Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antibody Drug Conjugate (ADC)

Table 3. Key Players of Bispecific Antibody (BsAb)

Table 4. Key Players of Antibody-radionuclide Conjugates

Table 5. Global Next Generation Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Next Generation Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Next Generation Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Next Generation Monoclonal Antibodies Market Share by Region (2020-2025)

Table 9. Global Next Generation Monoclonal Antibodies Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Next Generation Monoclonal Antibodies Market Share by Region (2026-2031)

Table 11. Next Generation Monoclonal Antibodies Market Trends

Table 12. Next Generation Monoclonal Antibodies Market Drivers

Table 13. Next Generation Monoclonal Antibodies Market Challenges

Table 14. Next Generation Monoclonal Antibodies Market Restraints

Table 15. Global Next Generation Monoclonal Antibodies Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Next Generation Monoclonal Antibodies Market Share by Players (2020-2025)

Table 17. Global Top Next Generation Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Monoclonal Antibodies as of 2024)

Table 18. Ranking of Global Top Next Generation Monoclonal Antibodies Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Next Generation Monoclonal Antibodies Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Next Generation Monoclonal Antibodies, Headquarters and Area Served

Table 21. Global Key Players of Next Generation Monoclonal Antibodies, Product and Application

Table 22. Global Key Players of Next Generation Monoclonal Antibodies, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Next Generation Monoclonal Antibodies Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Next Generation Monoclonal Antibodies Revenue Market Share by Type (2020-2025)

Table 26. Global Next Generation Monoclonal Antibodies Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Next Generation Monoclonal Antibodies Revenue Market Share by Type (2026-2031)

Table 28. Global Next Generation Monoclonal Antibodies Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Next Generation Monoclonal Antibodies Revenue Market Share by Application (2020-2025)

Table 30. Global Next Generation Monoclonal Antibodies Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Next Generation Monoclonal Antibodies Revenue Market Share by Application (2026-2031)

Table 32. North America Next Generation Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Next Generation Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Next Generation Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Next Generation Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Next Generation Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Next Generation Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Next Generation Monoclonal Antibodies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Next Generation Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Next Generation Monoclonal Antibodies Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Next Generation Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Next Generation Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Next Generation Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Next Generation Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Next Generation Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Next Generation Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 47. Roche Company Details

Table 48. Roche Business Overview

Table 49. Roche Next Generation Monoclonal Antibodies Product

Table 50. Roche Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 51. Roche Recent Development

Table 52. Amgen Company Details

Table 53. Amgen Business Overview

Table 54. Amgen Next Generation Monoclonal Antibodies Product

Table 55. Amgen Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 56. Amgen Recent Development

Table 57. Pfizer Company Details

Table 58. Pfizer Business Overview

Table 59. Pfizer Next Generation Monoclonal Antibodies Product

Table 60. Pfizer Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 61. Pfizer Recent Development

Table 62. Takeda Company Details

Table 63. Takeda Business Overview

Table 64. Takeda Next Generation Monoclonal Antibodies Product

Table 65. Takeda Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 66. Takeda Recent Development

Table 67. Daiichi Sankyo Company Details

Table 68. Daiichi Sankyo Business Overview

Table 69. Daiichi Sankyo Next Generation Monoclonal Antibodies Product

Table 70. Daiichi Sankyo Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 71. Daiichi Sankyo Recent Development

Table 72. Seagen Company Details

Table 73. Seagen Business Overview

Table 74. Seagen Next Generation Monoclonal Antibodies Product

Table 75. Seagen Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 76. Seagen Recent Development

Table 77. Astellas Company Details

Table 78. Astellas Business Overview

Table 79. Astellas Next Generation Monoclonal Antibodies Product

Table 80. Astellas Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 81. Astellas Recent Development

Table 82. Gilead Sciences Company Details

Table 83. Gilead Sciences Business Overview

Table 84. Gilead Sciences Next Generation Monoclonal Antibodies Product

Table 85. Gilead Sciences Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 86. Gilead Sciences Recent Development

Table 87. GSK Company Details

Table 88. GSK Business Overview

Table 89. GSK Next Generation Monoclonal Antibodies Product

Table 90. GSK Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 91. GSK Recent Development

Table 92. Immunocore Company Details

Table 93. Immunocore Business Overview

Table 94. Immunocore Next Generation Monoclonal Antibodies Product

Table 95. Immunocore Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 96. Immunocore Recent Development

Table 97. ADC Therapeutics Company Details

Table 98. ADC Therapeutics Business Overview

Table 99. ADC Therapeutics Next Generation Monoclonal Antibodies Product

Table 100. ADC Therapeutics Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 101. ADC Therapeutics Recent Development

Table 102. Bayer Company Details

Table 103. Bayer Business Overview

Table 104. Bayer Next Generation Monoclonal Antibodies Product

Table 105. Bayer Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 106. Bayer Recent Development

Table 107. Novartis Company Details

Table 108. Novartis Business Overview

Table 109. Novartis Next Generation Monoclonal Antibodies Product

Table 110. Novartis Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 111. Novartis Recent Development

Table 112. Lantheus Company Details

Table 113. Lantheus Business Overview

Table 114. Lantheus Next Generation Monoclonal Antibodies Product

Table 115. Lantheus Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 116. Lantheus Recent Development

Table 117. Aurobindo Pharma Company Details

Table 118. Aurobindo Pharma Business Overview

Table 119. Aurobindo Pharma Next Generation Monoclonal Antibodies Product

Table 120. Aurobindo Pharma Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 121. Aurobindo Pharma Recent Development

Table 122. Mundipharma Company Details

Table 123. Mundipharma Business Overview

Table 124. Mundipharma Next Generation Monoclonal Antibodies Product

Table 125. Mundipharma Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 126. Mundipharma Recent Development

Table 127. AbbVie Company Details

Table 128. AbbVie Business Overview

Table 129. AbbVie Next Generation Monoclonal Antibodies Product

Table 130. AbbVie Revenue in Next Generation Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 131. AbbVie Recent Development

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

Table 135. Authors List of This Report

List of Figures

Figure 1. Next Generation Monoclonal Antibodies Picture

Figure 2. Global Next Generation Monoclonal Antibodies Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Next Generation Monoclonal Antibodies Market Share by Type: 2024 VS 2031

Figure 4. Antibody Drug Conjugate (ADC) Features

Figure 5. Bispecific Antibody (BsAb) Features

Figure 6. Antibody-radionuclide Conjugates Features

Figure 7. Global Next Generation Monoclonal Antibodies Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Next Generation Monoclonal Antibodies Market Share by Application: 2024 VS 2031

Figure 9. Immune Diseases Case Studies

Figure 10. Cancer Case Studies

Figure 11. Other Case Studies

Figure 12. Next Generation Monoclonal Antibodies Report Years Considered

Figure 13. Global Next Generation Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Next Generation Monoclonal Antibodies Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Next Generation Monoclonal Antibodies Market Share by Region: 2024 VS 2031

Figure 16. Global Next Generation Monoclonal Antibodies Market Share by Players in 2024

Figure 17. Global Top Next Generation Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Monoclonal Antibodies as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Next Generation Monoclonal Antibodies Revenue in 2024

Figure 19. North America Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Next Generation Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 21. United States Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Next Generation Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 25. Germany Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Next Generation Monoclonal Antibodies Market Share by Region (2020-2031)

Figure 33. China Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Next Generation Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 41. Mexico Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Next Generation Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 45. Turkey Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Next Generation Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Roche Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 49. Amgen Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 51. Takeda Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 52. Daiichi Sankyo Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 53. Seagen Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 54. Astellas Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 55. Gilead Sciences Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 56. GSK Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 57. Immunocore Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 58. ADC Therapeutics Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 59. Bayer Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 60. Novartis Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 61. Lantheus Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 62. Aurobindo Pharma Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 63. Mundipharma Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 64. AbbVie Revenue Growth Rate in Next Generation Monoclonal Antibodies Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Therapeutic Monoclonal Antibodies Market Research Report 2024

Global Monoclonal Antibodies Product Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024

Global Arthritis Monoclonal Antibodies Market Research Report 2024

Global Next Generation Antibody Drug Market Research Report 2024

Global Monoclonal Antibody Development Services Market Research Report 2024

Global Long Acting Monoclonal Antibodies Market Research Report 2024

Global Myoglobin Monoclonal Antibody Market Research Report 2024

Monoclonal Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030

Global Monoclonal Antibody Reagent Market Research Report 2025

Global Anti CD25 Monoclonal Antibody Market Research Report 2024

Global Antibody drug Conjugates Market Insights Forecast to 2030

Global Research Monoclonal Antibodies and Reagents Market Research Report 2024

Global Hybridoma Antibody Discovery Platform Market Research Report 2025

Global Ubiquitin Monoclonal Antibody Market Research Report 2024

Global Research Area Antibodies Market Research Report 2025

Global Small Molecule Antibodies Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions